Open Trials

At Shenandoah Oncology, research is an integral part of our comprehensive efforts to provide cancer patients in our community with access to the latest and most advanced therapies and treatment options.  As a member of US Oncology Research and as a clinical research affiliate of VCU Massey Cancer Center, we are pleased to share this list of clinical trials currently enrolling at our practice.
 

BREAST CANCER - ADJUVANT

USOR 20-210

Phase 4, Observational Breast Cancer Study for stage I-III hormone receptor positive (HR+) breast cancer that have been taking adjuvant endocrine therapy for 4-7 years. Breast Cancer Index (BCI) Registry Study.

BREAST CANCER – METASTATIC

USOR 20-227

Phase 3, randomized, double-blind study with SAR439859 + Palbociclib verses Letrozole + Palbociclib for ER (+), HER2 (-) with no prior systemic anti-cancer treatment for advanced disease.

NRG-BR006

Phase 3, randomized study of Pembrolizumab versus observation in patient with triple-negative breast cancer who have ≥1cm residual disease or positive lymph nodes after neoadjuvant chemotherapy.

BREAST CANCER - CARDIAC PREVENTION

WF-97415 (UPBEAT).

Understanding and predicting cancer events after treatment

COLORECTAL

A021703 (SOLARIS)

Phase 3, randomized, double-blind study of Vitamin D3 supplementation in patients with previously untreated metastatic colorectal cancer.

A221805 

Phase 2/3, randomized, double-blind, placebo-controlled study of duloxetine to prevent oxaliplatin-induced chemotherapy-induced peripheral neuropathy.